However, the uncomplicated co-segregation pattern seen in BRCA1 and BRCA2 families, where (almost) all BC patients carry the predisposing mutation and where mutation carriers have a high risk to develop cancer (typical for high penetrant monogenic diseases), is not found in CHEK2 families. Here, CHEK2 is linked to cancer.